[go: up one dir, main page]

AR056465A1 - COMPOSITIONS CONTAINING DERIVATIVES OF TAXANO - Google Patents

COMPOSITIONS CONTAINING DERIVATIVES OF TAXANO

Info

Publication number
AR056465A1
AR056465A1 ARP060103597A AR056465A1 AR 056465 A1 AR056465 A1 AR 056465A1 AR P060103597 A ARP060103597 A AR P060103597A AR 056465 A1 AR056465 A1 AR 056465A1
Authority
AR
Argentina
Prior art keywords
derivatives
taxano
ether
ester
compositions containing
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of AR056465A1 publication Critical patent/AR056465A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones basadas en derivados de taxano que comprenden una solucion de dichos derivados en un surfactante. Estas composiciones pueden ser utilizadas para preparar soluciones de perfusion. REIVINDICACION 1.- Una composicion farmacéutica adecuada para inyeccion o infusion intravenosa que comprende: - un derivado de taxano de formula (I) en donde R representa un átomo de hidrogeno o un radical acetilo y R1 representa un radical ter-butoxicarbonilamino o benzoilamino, - glicofurol como un solvente y, - un surfactante fisiologicamente aceptable seleccionado a partir del grupo consistente en cremophor, un éter o éster de polietilen glicol y un éter o éster de polioxietilen glicol.Compositions based on taxane derivatives comprising a solution of said derivatives in a surfactant. These compositions can be used to prepare perfusion solutions. CLAIM 1.- A pharmaceutical composition suitable for intravenous injection or infusion comprising: - a taxane derivative of formula (I) wherein R represents a hydrogen atom or an acetyl radical and R1 represents a tert-butoxycarbonylamino or benzoylamino radical, - glycofurol as a solvent and, - a physiologically acceptable surfactant selected from the group consisting of cremophor, an ether or ester of polyethylene glycol and an ether or ester of polyoxyethylene glycol.

ARP060103597 2005-08-19 2006-08-17 COMPOSITIONS CONTAINING DERIVATIVES OF TAXANO AR056465A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0517092A GB0517092D0 (en) 2005-08-19 2005-08-19 New compositions containing taxane derivatives

Publications (1)

Publication Number Publication Date
AR056465A1 true AR056465A1 (en) 2007-10-10

Family

ID=35098012

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103597 AR056465A1 (en) 2005-08-19 2006-08-17 COMPOSITIONS CONTAINING DERIVATIVES OF TAXANO

Country Status (3)

Country Link
AR (1) AR056465A1 (en)
GB (1) GB0517092D0 (en)
WO (1) WO2007020085A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1583562T3 (en) 2003-01-06 2011-09-19 Angiochem Inc Angiopep-1, Related Compounds and Uses thereof
BRPI0520032A2 (en) 2005-02-18 2009-04-14 Angiochem Inc molecules to carry a compound through the blood brain barrier
DK2233156T3 (en) 2005-07-15 2013-08-05 Angiochem Inc Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
WO2007134354A1 (en) * 2006-05-23 2007-11-29 Ebewe Pharma Ges.M.B.H. Nfg. Kg Pharmaceutical formulation
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
AR063111A1 (en) * 2007-10-03 2008-12-30 Eriochem Sa A PHARMACEUTICAL FORMULATION OF TAXANO
KR101053780B1 (en) * 2008-02-29 2011-08-02 동아제약주식회사 Single liquid stable pharmaceutical composition containing docetaxel
CN102014925B (en) 2008-03-07 2013-02-06 赛多斯有限责任公司 Fulvestrant formulations
AU2009238187B2 (en) * 2008-04-18 2014-03-06 Angiochem Inc. Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
ES2344674B1 (en) * 2008-08-07 2011-06-29 Gp Pharm, S.A. INJECTABLE PHARMACEUTICAL COMPOSITION OF TAXANOS.
CA2740316A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
CA2745524C (en) 2008-12-05 2020-06-09 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
BRPI0922611A2 (en) 2008-12-17 2018-11-06 Angiochem Inc type 1 membrane matrix metalloprotein inhibitors and uses thereof
US9173891B2 (en) 2009-04-20 2015-11-03 Angiochem, Inc. Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
EP2448965A4 (en) 2009-07-02 2015-02-11 Angiochem Inc Multimeric peptide conjugates and uses thereof
US7772274B1 (en) 2009-10-19 2010-08-10 Scidose, Llc Docetaxel formulations with lipoic acid
US8912228B2 (en) 2009-10-19 2014-12-16 Scidose Llc Docetaxel formulations with lipoic acid
WO2012092421A2 (en) * 2010-12-30 2012-07-05 Surmodics, Inc. Composition for intravascular delivery of therapeutic composition
WO2013024495A1 (en) * 2011-08-18 2013-02-21 Dr. Reddys Laboratories Limited Pharmaceutical formulations of cabazitaxel
US11179468B2 (en) 2012-04-09 2021-11-23 Eagle Pharmaceuticals, Inc. Fulvestrant formulations
EP2875814B1 (en) * 2012-07-19 2018-08-22 FUJIFILM Corporation Liquid composition containing taxane-based active ingredient, process for producing same, and liquid medicinal preparation
EP2880021A4 (en) 2012-07-31 2015-06-17 Yung Shin Pharm Ind Co Ltd Amorphous cabazitaxel
TWI599373B (en) * 2012-08-15 2017-09-21 永信藥品工業股份有限公司 Stable pharmaceutical formulation of cabazitaxel
JP6285725B2 (en) * 2014-01-16 2018-02-28 ナガセ医薬品株式会社 Ethanol-free docetaxel pharmaceutical composition
DK3307326T3 (en) 2015-06-15 2020-10-19 Angiochem Inc METHODS FOR THE TREATMENT OF LEPTOMENINGAL CARCINOMATOSIS
US10188626B2 (en) 2015-11-03 2019-01-29 Cipla Limited Stabilized cabazitaxel formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (en) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa NEW PHARMACEUTICAL COMPOSITIONS BASED ON DERIVATIVES OF THE TAXANE CLASS.
FR2698543B1 (en) * 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa New taxoid-based compositions.
AU724842B2 (en) * 1995-12-21 2000-09-28 Genelabs Technologies, Inc. Taxane composition and method
US6919370B2 (en) * 2000-11-28 2005-07-19 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
KR20050099311A (en) * 2004-04-09 2005-10-13 에이엔에이치 케어연구소(주) Composition for injection comprising anticancer drug

Also Published As

Publication number Publication date
WO2007020085A3 (en) 2007-11-08
WO2007020085A2 (en) 2007-02-22
GB0517092D0 (en) 2005-09-28

Similar Documents

Publication Publication Date Title
AR056465A1 (en) COMPOSITIONS CONTAINING DERIVATIVES OF TAXANO
GT200600518A (en) PIRIMIDINE DERIVATIVES
EA200300323A1 (en) DERIVATIVES OF GUANIDININOBENZAMIDE (OPTIONS), COMPOSITION (OPTIONS), METHOD OF TREATMENT OF MEDIATED DISTRIBUTIONS mc4-r
AR067316A1 (en) OXYGEN SEQUESTING MOLECULES, ITEMS CONTAINING THEM AND METHODS FOR USE
MX2010003224A (en) Biaryl sulfonamide derivatives.
AR050918A1 (en) SOLUTION FOR INFUSION OF DIHYDROPTERIDINONES STABILIZED FOR STORAGE
ECSP099780A (en) NEW MACROCICLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
UY30819A1 (en) DERIVATIVES OF PIRAZOL, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
ECSP099792A (en) NEW INHIBITING PEPTIDES FOR HEPATITIS C VIRUS REPLICATION
CY1112831T1 (en) AZABIRENYLAMINBENZOIC ACID DERIVATIVES AS DHODH SUPPLY AGENTS
DE60017831D1 (en) DERIVATIVE COMPOSITIONS
PE20120032A1 (en) ORAL PHARMACEUTICAL COMPOSITION OF A DERIVATIVE OF N- [4- (8-BROMO-7-METOXYQUINOLIN-2-IL) -1,3-THIAZOL-2-IL] -2-METHYLPROPANAMIDE
TW200626558A (en) Indazolone derivatives
CR10485A (en) STABLE PHARMACEUTICAL COMPOSITION CONTAINING DOCETAXEL AND METHOD FOR MANUFACTURING
RU2010139958A (en) STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING DOCETSAXEL
UY31406A1 (en) "SOLID DISPERSION PRODUCT CONTAINING A N-ARIL UREA BASED COMPOUND".
RU2008142261A (en) PHARMACEUTICAL COMPOSITION WITH MODIFIED RELEASE AND ITS APPLICATION
AR109357A2 (en) PARENTERAL PHARMACEUTICAL COMPOSITION WITH TOLERANCE IN THE INJECTION SITE
EA201101085A1 (en) PHENOXYACIC ACIDS AS PPAR DELTA ACTIVATORS
CR9703A (en) DERIVATIVES OF PIRAZOLONA
RU2010123618A (en) IMICIMODE COMPOSITION
DK1377164T3 (en) Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
CO6501175A2 (en) DERIVATIVES OF BENZOTIAZINES, ITS PREPARATION AND APPLICATION AS DRUGS
AR054790A1 (en) METHODS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
PE20140134A1 (en) METHODS TO IMPROVE OXYGENATION OF ENDANGERED TISSUE

Legal Events

Date Code Title Description
FB Suspension of granting procedure